Jen Wieczner

Stay informed with Jen Wieczner’s coverage and analysis for Fortune.

Page 44 of 51

  • US-POLITICS-OBAMA-HEALTHCAREHealth

    Here’s one way Obamacare is backfiring

    By
  • Heather Bresch CEO of Mylan a global pharmaceutical companyMPW

    Why Wall Street loves to hate Mylan’s CEO

    By
  • Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 BillionFinance

    This drug-industry deal would be the largest hostile takeover in history

    By
  • Cevian Capital hedge fundFinance

    Meet Europe’s best activist investor

    By
  • Apple store beside the West lake in Hangzhou , is theTech

    Apple’s stock is now officially in a bear market

    By
  • INDONESIA-TRANSPORT-TRAFFIC-INTERNETTech

    Indonesia’s ‘Uber of moto-taxis’ is even more hated than Uber

    By
  • Walmart CEO Doug McMillon.Retail

    Walmart CEO Doug McMillon posts $25 million gift on Instagram

    By
  • Cindy Whitehead, CEO of Sprout Pharmaceuticals.MPW

    Valeant had the hots for ‘female Viagra,’ Sprout CEO says

    By
  • Tech

    Here’s what happened inside Google HQ when Alphabet was announced

    By
  • General Economy Images In BangladeshFinance

    Depomed goes hostile against Horizon Pharma’s takeover bid

    By
  • Zimbabwe Lion KilledInternational

    How much Delta’s lion head trophy ban could cost Africa’s economy

    By
  • A Best Buy store in Huntington Beach, CARetail

    Apple Watch arrived at Best Buy today

    By
  • Brenton Saunders, David PyottFinance

    From Actavis to Allergan: One pharma company’s wild dealmaking journey

    By Stacy Jones, Kacy Burdette, and others
  • A Teva Pharmaceutical Industries factory in Jerusalem, Israel.Finance

    The real reasons for the pharma merger boom

    By
  • Finance

    These are the best Global 500 stocks to buy

    By